Publications
Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome." Scientific Reports 13, no. 1 (2023).
"Chemotherapeutic drug screening in 3D-Bioengineered human myobundles provides insight into taxane-induced myotoxicities." Iscience 25, no. 10 (2022).
"Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle." Frontiers in Physiology 13 (2022).
"In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System." Methods in Molecular Biology (Clifton, N.J.) 2375 (2022): 77-90.
"Late onset cardiovascular dysfunction in adult mice resulting from galactic cosmic ray exposure." Iscience 25, no. 4 (2022).
"Patient- and Ventilator-Specific Modeling to Drive the Use and Development of 3D Printed Devices for Rapid Ventilator Splitting During the COVID-19 Pandemic." In Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 137-149. Vol. 13352 LNCS. 2022.
"Principles for the design of multicellular engineered living systems." Apl Bioengineering 6, no. 1 (2022).
"Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells." J Tissue Eng Regen Med 16, no. 2 (2022): 128-139.
"Biofabrication of tissue engineering vascular systems." Apl Bioengineering 5, no. 2 (2021).
"Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models." Frontiers in Cardiovascular Medicine 8 (2021).
"Differentiation and characterization of human iPSC-derived vascular endothelial cells under physiological shear stress." Star Protocols 2, no. 2 (2021).
"Emulating Early Atherosclerosis in a Vascular Microphysiological System Using Branched Tissue-Engineered Blood Vessels." Advanced Biology 5, no. 4 (2021).
"The NIH Somatic Cell Genome Editing program." Nature 592, no. 7853 (2021): 195-204.
"Application of Oxidative Stress to a Tissue-Engineered Vascular Aging Model Induces Endothelial Cell Senescence and Activation." Cells 9, no. 5 (2020).
"The future of biomedical engineering: Bioengineering of organoids and tissue development." Current Opinion in Biomedical Engineering 13 (2020): A1-A2.
"Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle." Tissue Engineering and Regenerative Medicine 17, no. 6 (2020): 801-813.
"Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts." Cell Stem Cell 26, no. 2 (2020): 136-137.
"iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome." Stem Cell Reports 14, no. 2 (2020): 325-337.
"Modeling early stage atherosclerosis in a primary human vascular microphysiological system." Nature Communications 11, no. 1 (2020).
"Modeling statin myopathy in a human skeletal muscle microphysiological system." Plos One 15, no. 11 (2020).
"A novel in situ monitoring system of 3D engineered muscle." In 21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, Microtas 2017, 1037-1038. 2020.
"Circulating mitochondria in organ donors promote allograft rejection." Am J Transplant 19, no. 7 (2019): 1917-1929.
"The future of biomedical engineering — digital health." Current Opinion in Biomedical Engineering 9 (2019): A1-A2.
"Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered Myobundles." Ann Biomed Eng 47, no. 7 (2019): 1596-1610.
"Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions." Apl Bioengineering 3, no. 2 (2019).
"